A. S. Ishkanian, G. Zafarana, J. Thoms, and R. G. Bristow, “Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer”, AO, vol. 49, no. 7, pp. 888–894, Oct. 2010.